JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

Search

Simulations Plus Inc

Slēgts

SektorsVeselības aprūpe

17.59 14.07

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

16.22

Max

18.11

Galvenie mērījumi

By Trading Economics

Ienākumi

-70M

-67M

Pārdošana

-2.1M

20M

P/E

Sektora vidējais

48.528

37.461

Dividenžu ienesīgums

0.48

Peļņas marža

-330.585

Darbinieki

243

EBITDA

-79M

-74M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+2.83% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

0.48%

2.33%

Nākamie ieņēmumi

2025. g. 29. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-28M

323M

Iepriekšējā atvēršanas cena

3.52

Iepriekšējā slēgšanas cena

17.59

Ziņu noskaņojums

By Acuity

38%

62%

133 / 371 Rangs Healthcare

Simulations Plus Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 22. okt. 22:47 UTC

Iegādes, apvienošanās, pārņemšana

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

2025. g. 22. okt. 22:13 UTC

Iegādes, apvienošanās, pārņemšana

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

2025. g. 22. okt. 21:20 UTC

Peļņas

Correction to IBM 3Q Sales Jump Article

2025. g. 22. okt. 20:57 UTC

Peļņas

SAP Posts Higher 3Q Revenue, Operating Profit

2025. g. 22. okt. 23:46 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 22. okt. 23:46 UTC

Tirgus saruna

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

2025. g. 22. okt. 23:41 UTC

Tirgus saruna

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

2025. g. 22. okt. 23:38 UTC

Tirgus saruna

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

2025. g. 22. okt. 23:15 UTC

Peļņas

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

2025. g. 22. okt. 22:28 UTC

Tirgus saruna

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

2025. g. 22. okt. 22:02 UTC

Peļņas

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

2025. g. 22. okt. 21:59 UTC

Iegādes, apvienošanās, pārņemšana

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

2025. g. 22. okt. 21:58 UTC

Iegādes, apvienošanās, pārņemšana

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

2025. g. 22. okt. 21:57 UTC

Iegādes, apvienošanās, pārņemšana

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

2025. g. 22. okt. 21:56 UTC

Iegādes, apvienošanās, pārņemšana

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

2025. g. 22. okt. 21:47 UTC

Iegādes, apvienošanās, pārņemšana

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

2025. g. 22. okt. 21:47 UTC

Peļņas

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

2025. g. 22. okt. 21:47 UTC

Iegādes, apvienošanās, pārņemšana

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

2025. g. 22. okt. 21:46 UTC

Iegādes, apvienošanās, pārņemšana

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

2025. g. 22. okt. 21:45 UTC

Iegādes, apvienošanās, pārņemšana

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

2025. g. 22. okt. 21:45 UTC

Iegādes, apvienošanās, pārņemšana

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

2025. g. 22. okt. 21:28 UTC

Tirgus saruna
Peļņas

Correction to Alcoa Tariff Market Talk

2025. g. 22. okt. 21:25 UTC

Peļņas

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

2025. g. 22. okt. 21:17 UTC

Peļņas

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

2025. g. 22. okt. 21:09 UTC

Tirgus saruna
Peļņas

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

2025. g. 22. okt. 21:00 UTC

Tirgus saruna

ESG Roundup: Market Talk

2025. g. 22. okt. 20:59 UTC

Peļņas

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

2025. g. 22. okt. 20:51 UTC

Peļņas

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

2025. g. 22. okt. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 22. okt. 20:44 UTC

Peļņas

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Salīdzinājums

Cenas izmaiņa

Simulations Plus Inc Prognoze

Cenas mērķis

By TipRanks

2.83% augšup

Prognoze 12 mēnešiem

Vidējais 16 USD  2.83%

Augstākais 16 USD

Zemākais 16 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Simulations Plus Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

3 ratings

1

Pirkt

2

Turēt

0

Pārdot

Noskaņojums

By Acuity

133 / 371 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat